CSX
57
-4
MAR
63
-5
SWKS
38
-2
ESS
62
-3
PYPL
52
-2
WMT
56
-4
K
51
-3
PCAR
56
-5
DLTR
38
-4
COF
62
3
ZTS
47
2
SLB
52
-3
LUV
45
-2
KLAC
38
-6
LLY
28
-8
ROP
53
-9
ADSK
66
-4
AON
54
2
ABT
59
2
TROW
47
-6
CSX
57
-4
MAR
63
-5
SWKS
38
-2
ESS
62
-3
PYPL
52
-2
WMT
56
-4
K
51
-3
PCAR
56
-5
DLTR
38
-4
COF
62
3
ZTS
47
2
SLB
52
-3
LUV
45
-2
KLAC
38
-6
LLY
28
-8
ROP
53
-9
ADSK
66
-4
AON
54
2
ABT
59
2
TROW
47
-6
Financhill
Back

iShares MSCI Belgium ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

EWK
iShares MSCI Belgium ETF

Last Price:
18.90
Seasonality Move:
1.29%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
50
iShares MSCI Belgium ETF (EWK) is a Sell

Is iShares MSCI Belgium ETF a Buy, Sell or Hold?

  • The current iShares MSCI Belgium ETF [EWK] share price is $18.90. The Score for EWK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EWK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EWK Stock Price Chart

What is iShares MSCI Belgium ETF's stock price today?

  • The iShares MSCI Belgium ETF share price today is $18.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWK is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EWK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 27.31 Sell
Chaikin Money Flow: -2601 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.48 - 20.38) Sell
Bollinger Bands (100): (19.22 - 20.44) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EWK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.39 Sell
20-day SMA: 19.8 Sell
50-day SMA: 20.23 Sell
200-day SMA: 19.27 Sell
8-day EMA: 19.34 Sell
20-day EMA: 19.7 Sell
50-day EMA: 19.94 Sell
200-day EMA: 19.4 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Belgium ETF Earnings Growth & EWK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

iShares MSCI Belgium ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):